The era of precision medicine is now.

TSH provide various convenient, time-saving, and accurate detection.

  • Disease screening

    Current risk assessment

    MPapⓇ test
    • Minimally invasive.
    • Development based on large clinical study in Taiwan, first in the world.
    • Fast and accurately evaluate endometrial cancer risk.
  • Disease Monitor

    Surgery or treatment follow-up

    AlphaLiquidⓇ100
    • Non-invasive liquid biopsy (ctDNA or CTC).
    • Real-time monitoring.
    • ctDNA NGS sequencing.
    • CTC test based on large CRC clinical study in Taiwan.
    • MRD follow-up.
  • Medication Guidelines

    Comprehensive targeted therapies survey

    AlphaLiquidⓇ100
    • Low false negativity and positivity ctDNA liquid biopsy.
    • Actionable drug related genes panel.
    • Flexible testing choices (body fluid / blood).
    • Completed mutation information(SNV / InDel / CNV/ Fusion / MSI / TMB)
    AlphaSolidⓇ
    • Low false negativity and positivity tissue biopsy.
    • Actionable drug related genes panel.
    • Completed mutation information(SNV / InDel / CNV/ Fusion / MSI / TMB)
    AlphaSolidⓇ
    • Low false negativity and positivity tissue biopsy.
    • DNA and RNA NGS sequencing.
    • Actionable drug related genes panel.
    • Completed mutation information(SNV / InDel / CNV/ Fusion / MSI / TMB)
    prosigna
    • Guideline Recommended(ASCO / ESMO / NCCN / NICE/ St. Gallen)
    • More comprehensive information
      • Risk Group
      • Risk of Recurrence
      • Probability of Distant Recurrence
      • Intrinsic Subtype